Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
Sung-Yeon Cho, Su-Mi Choi, Sun Hee Park, Dong-Gun Lee, Jung-Hyun Choi, Jin-Hong Yoo
Korean J Intern Med. 2016;31(1):156-161.   Published online 2015 Dec 28     DOI: https://doi.org/10.3904/kjim.2016.31.1.156
Citations to this article as recorded by Crossref logo
Comparison of three doses of amikacin on alternate days with a daily dose of meropenem during the same period for the treatment of urinary tract infection with E. coli: a double-blind clinical trial
Behzad Mohsenpour, Amjad Ahmadi, Hero Azizzadeh, Ebrahim Ghaderi, Katayon Hajibagheri, Shahla Afrasiabian, Gohar Lotfi, Zhila Farzinpoor
BMC Research Notes.2024;[Epub]     CrossRef
Prevalence of Extended Spectrum β-Lactamases-Producing Escherichia coli Isolated from Clinical Samples and Their Antibiotic Resistance Pattern
Mohammed Ja'afaru, Abubakar Gaure, Joel Ewansiha, Olumuyiwa Adeyemo
Journal of Medical Microbiology and Infectious Diseases.2023; 11(1): 34.     CrossRef
Antimicrobial susceptibility pattern of pathogens from urinary isolates of diabetic patients in a tertiary care hospital in South Tamil Nadu
S Nightingale Sheeba
Indian Journal of Microbiology Research.2023; 10(2): 68.     CrossRef
TEM,CTX-M,SHV Genes in ESBL-Producing Escherichia coli and Klebsiella pneumoniae Isolated from Clinical Samples in a County Clinical Emergency Hospital Romania-Predominance of CTX-M-15
Alice Elena Ghenea, Ovidiu Mircea Zlatian, Oana Mariana Cristea, Anca Ungureanu, Radu Razvan Mititelu, Andrei Theodor Balasoiu, Corina Maria Vasile, Alex-Ioan Salan, Daniel Iliuta, Mihaela Popescu, Anca-Loredana Udriștoiu, Maria Balasoiu
Antibiotics.2022; 11(4): 503.     CrossRef
Reported Cases of Urinary Tract Infections and the Susceptibility of Uropathogens from Hospitals in Northern Ghana
Akosua B Karikari, Courage KS Saba, David Y Yamik
Microbiology Insights.2022; 15: 117863612211061.     CrossRef
Characteristics of Escherichia coli Urine Isolates and Risk Factors for Secondary Bloodstream Infections in Patients with Urinary Tract Infections
Hyeon Jin Choi, Seok Hoon Jeong, Kyeong Seob Shin, Young Ah Kim, Young Ree Kim, Hyun Soo Kim, Jong Hee Shin, Jeong Hwan Shin, Young Uh, Songmee Bae, Eun-Jeong Yoon, Jung Sik Yoo, Karen C. Carroll
Microbiology Spectrum.2022;[Epub]     CrossRef
Extended‐spectrum β‐lactamase‐producing and carbapenem‐resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches
Elena Pérez‐Nadales, Mario Fernández‐Ruiz, Belén Gutiérrez‐Gutiérrez, Álvaro Pascual, Jesús Rodríguez‐Baño, Luis Martínez‐Martínez, José María Aguado, Julian Torre‐Cisneros
Transplant Infectious Disease.2022;[Epub]     CrossRef
Antimicrobial Resistance and Virulence Factors of Proteus mirabilis Isolated from Dog with Chronic Otitis Externa
Jun Kwon, Myoung-Hwan Yang, Hyoung-Joon Ko, Sang-Guen Kim, Chul Park, Se-Chang Park
Pathogens.2022; 11(10): 1215.     CrossRef
Single-dose amikacin plus 7 days of amoxicillin/clavulanate to treat acute cystitis caused by extended-spectrum beta-lactamase-producing Escherichia coli: A retrospective cohort study
Sun Tae Ahn, Da Eun Han, Dong Hyun Lee, Jong Wook Kim, Hong Seok Park, Du Geon Moon, Mi Mi Oh
Investigative and Clinical Urology.2021; 62(3): 310.     CrossRef
High Rates of Antibiotic Nonsusceptibility in Gram-negative Urinary Tract Infection in Children With Risk Factors Occurring in the Preceding Month
Gavriel Hain, Aviv Goldbart, Orli Sagi, Shalom Ben-Shimol
Pediatric Infectious Disease Journal.2021; 40(7): 639.     CrossRef
Retrospective assessment of antimicrobial stewardship initiative in outpatient use of ertapenem for uncomplicated extended spectrum beta lactamase Enterobacteriaceae urinary tract infections
Carrie P. Wong, Thomas Delate, Elizabeth Hudson, Julia K. Nguyen, Su-Jau Yang, Mariana Abraham
BMC Infectious Diseases.2021;[Epub]     CrossRef
Relationship Between Antibiotic Resistance Patterns and O-Serogroups in Uropathogenic Escherichia coli Strains Isolated from Iraqi Patients
Eman Jassim Mohammed, Mohammed Allami, Mohammad Reza Sharifmoghadam, Masoumeh Bahreini
Jundishapur Journal of Microbiology.2021;[Epub]     CrossRef
Antibiotics for complicated urinary tract infection and acute pyelonephritis: A systematic review
Leong Tung Ong
World Journal of Clinical Infectious Diseases.2020; 10(3): 33.     CrossRef
Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients
B. Gutiérrez-Gutiérrez, J. Rodríguez-Baño
Clinical Microbiology and Infection.2019; 25(8): 932.     CrossRef
Noncarbapenems for the Treatment of Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Bacteria
C. Whitney White, Jeffrey A. Kyle, Crystal M. Deas, Jacob Campbell
Southern Medical Journal.2019; 112(8): 438.     CrossRef
Extended spectrum β-lactamase producing enterobacteriaceae: carbapenem sparing options
Abdullah Tarık Aslan, Murat Akova
Expert Review of Anti-infective Therapy.2019; 17(12): 969.     CrossRef
Optimizing Amikacin Dosage in Pediatrics Based on Population Pharmacokinetic/Pharmacodynamic Modeling
Saeed Alqahtani, Manal Abouelkheir, Abdullah Alsultan, Yasmine Elsharawy, Aljawharah Alkoraishi, Reem Osman, Wael Mansy
Pediatric Drugs.2018; 20(3): 265.     CrossRef
Clinical Practice Guidelines for the Antibiotic Treatment of Community-Acquired Urinary Tract Infections
Cheol-In Kang, Jieun Kim, Dae Won Park, Baek-Nam Kim, U-Syn Ha, Seung-Ju Lee, Jeong Kyun Yeo, Seung Ki Min, Heeyoung Lee, Seong-Heon Wie
Infection & Chemotherapy.2018; 50(1): 67.     CrossRef
Stopping the effective non-fluoroquinolone antibiotics at day 7 vs continuing until day 14 in adults with acute pyelonephritis requiring hospitalization: A randomized non-inferiority trial
Pavankumar Rudrabhatla, Surendran Deepanjali, Jharna Mandal, Rathinam Palamalai Swaminathan, Tamilarasu Kadhiravan, Giuseppe Vittorio De Socio
PLOS ONE.2018; 13(5): e0197302.     CrossRef
Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study
Marianne Bollestad, Nils Grude, Sigrid Solhaug, Niclas Raffelsberger, Nina Handal, Hans-Johnny Schjelderup Nilsen, Monica Regine Romstad, Andreas Emmert, Yngvar Tveten, Arne Søraas, Pål A Jenum, Synne Jenum, Janne Møller-Stray, Einar Tollaksen Weme, Morte
Journal of Antimicrobial Chemotherapy.2018; 73(9): 2503.     CrossRef
Urinary Tract Infections among Bladder Outlet Obstruction Patients in Accra, Ghana: Aetiology, Antibiotic Resistance, and Risk Factors
Karikari Asafo-Adjei, James Mensah, Appiah-Korang Labi, Nicholas Dayie, Eric Donkor
Diseases.2018; 6(3): 65.     CrossRef
Treatment of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBLs) infections: what have we learned until now?
Zoi Dorothea Pana, Theoklis Zaoutis
F1000Research.2018; 7: 1347.     CrossRef
In vitro efficacy of 16 antimicrobial drugs against a large collection of β-lactamase-producing isolates of extraintestinal pathogenic Escherichia coli from dogs and cats
Takae Shimizu, Kazuki Harada, Yuzo Tsuyuki, Yui Kimura, Tadashi Miyamoto, Shingo Hatoya, Yoshiaki Hikasa
Journal of Medical Microbiology.2017; 66(8): 1085.     CrossRef
Amikacin/ciclosporin/prednisolone
Reactions Weekly.2016; 1588(1): 25.     CrossRef
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation
Ido M. Herzog, Sivan Louzoun Zada, Micha Fridman
Journal of Medicinal Chemistry.2016; 59(17): 8008.     CrossRef